Momordicine I, a triterpene from bitter melon ( Momordica charantia L.), ameliorates alcohol-associated liver disease: research on the possible liver benefits | Synapse
Momordicine I, a triterpene from bitter melon ( Momordica charantia L.), ameliorates alcohol-associated liver disease: research on the possible liver benefits
The aim is to explore the hepatoprotective effects of Momordicine I on alcohol-associated liver disease.
Isolated Momordicine I from Momordica charantia L.
Conducted bioactivity assessments related to liver health.
Momordicine I showed potential protective effects on liver function.
Improvements in liver health metrics were observed.
Abstract
Momordicine I (M-I), a key bioactive and bitter-tasting triterpenoid in Momordica charantia L., has attracted significant research interest due to its potential hepatoprotective effects.